Detalles de la búsqueda
1.
Prognostic significance of initial tumor shrinkage in patients with stage III non-small cell lung cancer treated with durvalumab following chemoradiotherapy.
Int J Clin Oncol
; 29(2): 115-123, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38032455
2.
Nivolumab-induced radiation recall pneumonitis in non-small-cell lung cancer patients with thoracic radiation therapy.
Cancer Sci
; 114(2): 630-639, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36285515
3.
First-line osimertinib in EGFR mutation-positive non-small cell lung cancer patients with poor performance status.
Future Oncol
; 18(3): 291-300, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34758637
4.
Medical management of older patients with lung cancer.
Jpn J Clin Oncol
; 52(10): 1082-1088, 2022 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35975674
5.
A case series on the safety of immunotherapy with reduced blood testing frequency in lung cancer patients.
Int J Clin Oncol
; 26(5): 851-857, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33656654
6.
Radiographic Assessment of Objective Responses Using the ITMIG-Modified Criteria in Thymic Carcinoma.
Oncology
; 97(5): 264-269, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31307031
7.
Re-challenging immune checkpoint inhibitor in a patient with advanced non-small cell lung cancer: a case report.
BMC Cancer
; 18(1): 302, 2018 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-29554874
8.
Brief Report: Clinical Outcomes by Infusion Timing of Immune Checkpoint Inhibitors in Patients With Locally Advanced NSCLC.
JTO Clin Res Rep
; 5(4): 100659, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38596201
9.
Osimertinib plus local treatment for brain metastases versus osimertinib alone in patients with EGFR-Mutant Non-Small Cell Lung Cancer.
Lung Cancer
; 191: 107540, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38614069
10.
The Gut Microbiome from a Biomarker to a Novel Therapeutic Strategy for Immunotherapy Response in Patients with Lung Cancer.
Curr Oncol
; 30(11): 9406-9427, 2023 Oct 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37999101
11.
Lenvatinib rechallenge in a patient with advanced thymic carcinoma: A case report.
Thorac Cancer
; 13(23): 3408-3411, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36251511
12.
Efficacy of first-line immune checkpoint inhibitors in patients with advanced NSCLC with KRAS, MET, FGFR, RET, BRAF, and HER2 alterations.
Thorac Cancer
; 13(11): 1703-1711, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35491960
13.
Association between the baseline tumor size and outcomes of patients with non-small cell lung cancer treated with first-line immune checkpoint inhibitor monotherapy or in combination with chemotherapy.
Transl Lung Cancer Res
; 11(2): 135-149, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35280320
14.
A Multicenter, Randomized Phase III Study Comparing Platinum Combination Chemotherapy Plus Pembrolizumab With Platinum Combination Chemotherapy Plus Nivolumab and Ipilimumab for Treatment-Naive Advanced Non-Small Cell Lung Cancer Without Driver Gene Alterations: JCOG2007 (NIPPON Study).
Clin Lung Cancer
; 23(4): e285-e288, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34802879
15.
Clinicopathologic characteristics and diagnostic methods of RET rearrangement in Chinese non-small cell lung cancer patients.
Transl Lung Cancer Res
; 11(4): 617-631, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35529790
16.
Safety and efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients with preexisting antinuclear antibodies: a retrospective cohort study.
Transl Lung Cancer Res
; 11(7): 1420-1433, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35958331
17.
Tolerability, safety, and preliminary antitumor activity of fuzuloparib in combination with SHR-1316 in patients with relapsed small cell lung cancer: a multicenter, open-label, two-stage, phase Ib trial.
Transl Lung Cancer Res
; 11(6): 1069-1078, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35832454
18.
Cancer Cachexia among Patients with Advanced Non-Small-Cell Lung Cancer on Immunotherapy: An Observational Study with Exploratory Gut Microbiota Analysis.
Cancers (Basel)
; 14(21)2022 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36358821
19.
Polypharmacy among older advanced lung cancer patients taking EGFR tyrosine kinase inhibitors.
J Geriatr Oncol
; 12(1): 64-71, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32952094
20.
Cisplatin and Irinotecan as First-Line Chemotherapy for Previously Untreated Metastatic Thymic Carcinoma: Updated Analysis.
Front Oncol
; 11: 779700, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35111671